The Ohio Board of Pharmacy has banned the use of hydroxychloroquine as a treatment for COVID-19.
The board move taking effect Thursday. President Trump has baselessly touted the drug, which is typically used to treat conditions like lupus and malaria, as a way to possibly prevent or cure coronavirus.
Studies have shown the drug does not appear to be effective against coronavirus and can have serious side effects.
However, in a statement Thursday morning, Gov. Mike DeWine asked the pharmacy board to halt the rule from taking effect. DeWine wants the board to revisit the issue and "open the process up for comment and testimony from experts."
"The decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient," DeWine wrote.
The pharmacy board’s new rule replaces a previous rule issued on March 22 that authorized pharmacists to prescribe 14-day supplies of the anti-malarial drugs to patients with lab-confirmed cases of COVID-19.